DEXCOM INC
DXCM · XNASCIK 1093557fmd_168SR2DE6XQ6A282EJH0EPRFW9Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 68 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 573 | 719 | 1,032 | 1,476 | 1,927 | 2,449 | 2,910 | 3,622 | 4,033 | 4,662 |
| Cost of revenue | 195 | 226 | 368 | 545 | 647 | 768 | 1,027 | 1,333 | 1,595 | 1,860 |
| Gross profit | 378 | 492 | 664 | 932 | 1,280 | 1,681 | 1,883 | 2,289 | 2,438 | 2,802 |
| Realized investment gains (losses) | 0 | 0 | 80 | (4) | 0 | 12 | 0 | 2 | – | – |
| Research and development | 156 | 185 | 200 | 274 | 360 | 517 | 484 | 506 | 552 | 599 |
| Selling, general and administrative | 286 | 349 | 433 | 516 | 618 | 811 | 1,008 | 1,185 | 1,286 | 1,291 |
| Total operating expenses | 442 | 535 | 850 | 789 | 981 | 1,415 | 1,492 | 1,691 | 1,838 | 1,890 |
| Operating income | (64) | (43) | (186) | 142 | 300 | 266 | 391 | 598 | 600 | 912 |
| Interest expense | 1 | 13 | 23 | 60 | 18 | 19 | 19 | 20 | 19 | 18 |
| Interest and investment income | 0 | 3 | – | – | – | 2 | 24 | 135 | 134 | 113 |
| Other non-operating income (expense) | (1) | 7 | 2 | 26 | 16 | (9) | (0) | 113 | 109 | 177 |
| Income before taxes | (65) | (49) | (127) | 104 | 298 | 257 | 391 | 710 | 709 | 1,088 |
| Income tax expense | 1 | 2 | 1 | 3 | (252) | 40 | 50 | 169 | 133 | 252 |
| Net income from continuing operations | (66) | (50) | (127) | 101 | 550 | 217 | 341 | 542 | 576 | 836 |
| Net income | (66) | (50) | (127) | 101 | 550 | 217 | 341 | 542 | 576 | 836 |